Deep learning-assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study

被引:6
|
作者
Xu, Yang [1 ]
Zhou, Chaoyang [2 ]
He, Xiaojuan [1 ]
Song, Rao [1 ]
Liu, Yangyang [1 ]
Zhang, Haiping [1 ]
Wang, Yudong [3 ]
Fan, Qianrui [3 ]
Chen, Weidao [3 ]
Wu, Jiangfen [3 ]
Wang, Jian [2 ]
Guo, Dajing [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Radiol, Chongqing 400010, Peoples R China
[2] Army Mil Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing 400038, Peoples R China
[3] InferVision, Ocean Int Ctr, Inst Res, Beijing 100025, Peoples R China
关键词
Hepatocellular carcinoma (HCC); The Liver Imaging Reporting and Data System (LI-RADS); Deep learning (DL); Transformer; Computed tomography (CT);
D O I
10.1007/s00330-023-09857-w
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesTo develop a deep learning (DL) method that can determine the Liver Imaging Reporting and Data System (LI-RADS) grading of high-risk liver lesions and distinguish hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT.MethodsThis retrospective study included 1049 patients with 1082 lesions from two independent hospitals that were pathologically confirmed as HCC or non-HCC. All patients underwent a four-phase CT imaging protocol. All lesions were graded (LR 4/5/M) by radiologists and divided into an internal (n = 886) and external cohort (n = 196) based on the examination date. In the internal cohort, Swin-Transformer based on different CT protocols were trained and tested for their ability to LI-RADS grading and distinguish HCC from non-HCC, and then validated in the external cohort. We further developed a combined model with the optimal protocol and clinical information for distinguishing HCC from non-HCC.ResultsIn the test and external validation cohorts, the three-phase protocol without pre-contrast showed & kappa; values of 0.6094 and 0.4845 for LI-RADS grading, and its accuracy was 0.8371 and 0.8061, while the accuracy of the radiologist was 0.8596 and 0.8622, respectively. The AUCs in distinguishing HCC from non-HCC were 0.865 and 0.715 in the test and external validation cohorts, while those of the combined model were 0.887 and 0.808.ConclusionThe Swin-Transformer based on three-phase CT protocol without pre-contrast could feasibly simplify LI-RADS grading and distinguish HCC from non-HCC. Furthermore, the DL model have the potential in accurately distinguishing HCC from non-HCC using imaging and highly characteristic clinical data as inputs.
引用
收藏
页码:8879 / 8888
页数:10
相关论文
共 8 条
  • [1] Deep learning–assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study
    Yang Xu
    Chaoyang Zhou
    Xiaojuan He
    Rao Song
    Yangyang Liu
    Haiping Zhang
    Yudong Wang
    Qianrui Fan
    Weidao Chen
    Jiangfen Wu
    Jian Wang
    Dajing Guo
    European Radiology, 2023, 33 : 8879 - 8888
  • [2] Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria
    Ludwig, Daniel R.
    Fraum, Tyler J.
    Cannella, Roberto
    Tsai, Richard
    Naeem, Muhammad
    LeBlanc, Maverick
    Salter, Amber
    Tsung, Allan
    Fleckenstein, Jaquelyn
    Shetty, Anup S.
    Borhani, Amir A.
    Furlan, Alessandro
    Fowler, Kathryn J.
    HPB, 2019, 21 (12) : 1697 - 1706
  • [3] Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver
    Oestmann, Paula M.
    Wang, Clinton J.
    Savic, Lynn J.
    Hamm, Charlie A.
    Stark, Sophie
    Schobert, Isabel
    Gebauer, Bernhard
    Schlachter, Todd
    Lin, MingDe
    Weinreb, Jeffrey C.
    Batra, Ramesh
    Mulligan, David
    Zhang, Xuchen
    Duncan, James S.
    Chapiro, Julius
    EUROPEAN RADIOLOGY, 2021, 31 (07) : 4981 - 4990
  • [4] Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver
    Paula M. Oestmann
    Clinton J. Wang
    Lynn J. Savic
    Charlie A. Hamm
    Sophie Stark
    Isabel Schobert
    Bernhard Gebauer
    Todd Schlachter
    MingDe Lin
    Jeffrey C. Weinreb
    Ramesh Batra
    David Mulligan
    Xuchen Zhang
    James S. Duncan
    Julius Chapiro
    European Radiology, 2021, 31 : 4981 - 4990
  • [5] MRI-based deep learning radiomics to differentiate dual-phenotype hepatocellular carcinoma from HCC and intrahepatic cholangiocarcinoma: a multicenter study
    Wu, Qian
    Zhang, Tao
    Xu, Fan
    Cao, Lixiu
    Gu, Wenhao
    Zhu, Wenjing
    Fan, Yanfen
    Wang, Ximing
    Hu, Chunhong
    Yu, Yixing
    INSIGHTS INTO IMAGING, 2025, 16 (01):
  • [6] Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study
    Haohua Yao
    Li Tian
    Xi Liu
    Shurong Li
    Yuhang Chen
    Jiazheng Cao
    Zhiling Zhang
    Zhenhua Chen
    Zihao Feng
    Quanhui Xu
    Jiangquan Zhu
    Yinghan Wang
    Yan Guo
    Wei Chen
    Caixia Li
    Peixing Li
    Huanjun Wang
    Junhang Luo
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 15827 - 15838
  • [7] Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study
    Yao, Haohua
    Tian, Li
    Liu, Xi
    Li, Shurong
    Chen, Yuhang
    Cao, Jiazheng
    Zhang, Zhiling
    Chen, Zhenhua
    Feng, Zihao
    Xu, Quanhui
    Zhu, Jiangquan
    Wang, Yinghan
    Guo, Yan
    Chen, Wei
    Li, Caixia
    Li, Peixing
    Wang, Huanjun
    Luo, Junhang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (17) : 15827 - 15838
  • [8] CT-based deep learning radiomics and hematological biomarkers in the assessment of pathological complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma: A two-center study
    Zhang, Meng
    Lu, Yukun
    Sun, Hongfu
    Hou, Chuanke
    Zhou, Zichun
    Liu, Xiao
    Zhou, Qichao
    Li, Zhenjiang
    Yin, Yong
    TRANSLATIONAL ONCOLOGY, 2024, 39